Literature DB >> 17260007

Expression of the REG IV gene in ulcerative colitis.

Apichart Nanakin1, Hirokazu Fukui, Shigehiko Fujii, Akira Sekikawa, Naoki Kanda, Hiroshi Hisatsune, Hiroshi Seno, Yoshitaka Konda, Takahiro Fujimori, Tsutomu Chiba.   

Abstract

The regenerating gene (REG) IV gene was isolated from a cDNA library of ulcerative colitis (UC) tissues. However, its role in the pathophysiology of UC and subsequent development of colitic cancer is still unclear. We investigated the expression of the REG IV gene in UC and colitic cancer tissues and examined whether cytokines or growth factors are responsible for REG IV gene expression and whether REG IV gene induction affects cell growth and apoptosis in colon cancer cells. The expressions of REG IV and growth factor genes in UC tissues were analyzed by real time reverse transcription-polymerase chain reaction. The effects of cytokines and growth factors on REG IV gene expression were examined in SW403 cells by Northern blot analysis. The effects of REG IV gene induction on cell growth and H(2)O(2)-induced apoptosis were examined in DLD-1 cells by MTT and TUNEL assays, respectively. REG IV mRNA was strongly expressed in inflamed epithelium and in dysplasias and cancerous lesions in UC tissues. The level of REG IV mRNA expression was correlated with that of basic fibroblast growth factor (bFGF) as well as hepatocyte growth factor (HGF) mRNA expression in UC tissues. The REG IV gene expression in SW403 colon cancer cells was enhanced by stimulation with transforming growth factor-alpha, epidermal growth factor, bFGF, and HGF. REG IV gene induction promoted cell growth and conferred resistance to H(2)O(2)-induced apoptosis in DLD-1 cells. The REG IV gene is inducible by growth factors and may function as a growth promoting and/or an antiapoptotic factor in the pathophysiology of UC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17260007     DOI: 10.1038/labinvest.3700507

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  24 in total

1.  RegIV expression showing specificity to gastrointestinal tract and its potential role in diagnosing digestive tract neuroendocrine tumor.

Authors:  Feng-ying Li; Xiao-bin Ren; En-ping Xu; Qiong Huang; Hong-qiang Sheng; Bing-jian Lv; Mao-de Lai
Journal:  J Zhejiang Univ Sci B       Date:  2010-04       Impact factor: 3.066

2.  Up-regulated Reg proteins induced by Interleukin-22 treatment ameliorate acute liver injury in rat model.

Authors:  Hong-Bin Zhang; Hong-Chun Luo; Xiao-Juan Xin; Ai-Zhong Zeng
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Reg IV enhances peritoneal metastasis in gastric carcinomas.

Authors:  H Kuniyasu; N Oue; T Sasahira; L Yi; Y Moriwaka; T Shimomoto; K Fujii; H Ohmori; W Yasui
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

4.  Regenerating proteins and their expression, regulation and signaling.

Authors:  Abhirath Parikh; Anne-Fleur Stephan; Emmanuel S Tzanakakis
Journal:  Biomol Concepts       Date:  2011-11-10

5.  Establishment of a system to evaluate the therapeutic effect and the dynamics of an investigational drug on ulcerative colitis using human colonic organoids.

Authors:  Ryu Nishimura; Tomoaki Shirasaki; Kiichiro Tsuchiya; Yoshihide Miyake; Yusuke Watanabe; Shuji Hibiya; Sho Watanabe; Tetsuya Nakamura; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2019-01-01       Impact factor: 7.527

Review 6.  The Potential Role of REG Family Proteins in Inflammatory and Inflammation-Associated Diseases of the Gastrointestinal Tract.

Authors:  Chao Sun; Xiaoyu Wang; Yangyang Hui; Hirokazu Fukui; Bangmao Wang; Hiroto Miwa
Journal:  Int J Mol Sci       Date:  2021-07-03       Impact factor: 5.923

7.  Oncogenic reg IV is a novel prognostic marker for glioma patient survival.

Authors:  Qi Wang; Jianping Deng; Jun Yuan; Liang Wang; Zhenwei Zhao; Shiming He; Yongsheng Zhang; Yanyang Tu
Journal:  Diagn Pathol       Date:  2012-06-19       Impact factor: 2.644

8.  The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target.

Authors:  Aude Legoffic; Ezequiel Calvo; Carla Cano; Emma Folch-Puy; Marc Barthet; Jean Robert Delpero; Montse Ferrés-Masó; Jean Charles Dagorn; Daniel Closa; Juan Iovanna
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

9.  Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancer.

Authors:  Yutaka Naito; Naohide Oue; Takao Hinoi; Naoya Sakamoto; Kazuhiro Sentani; Hideki Ohdan; Kazuyoshi Yanagihara; Hiroki Sasaki; Wataru Yasui
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

10.  In vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progression.

Authors:  Che-Ming Liu; Chia-Ling Hsieh; Yun-Chi He; Sen-Jei Lo; Ji-An Liang; Teng-Fu Hsieh; Sajni Josson; Leland W K Chung; Mien-Chie Hung; Shian-Ying Sung
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.